Incidence of Nd:YAG laser capsulotomy following cataract surgery: a population-based nation-wide study – FreYAG1 study

BMC Ophthalmology

Research

François Lignereux¹  Cédric Schweitzer²  Corinne Dot³  Pascal Rozot⁴  Antoine Labbe⁵  Antoine P. Brézin⁶  Françoise Bugnard⁷  Mélanie Goguillot⁷ 

[1] Department of Ophthalmology Santé Atlantique Polyclinic, Nantes, France;Department of Ophthalmology, CHU Bordeaux, Univ. Bordeaux, ISPED, INSERM, U1219 – Bordeaux Population Health Research Centre, F-33000, Bordeaux, France;Department of Ophthalmology, Desgenettes Military Hospital, Lyon, France;Department of Ophthalmology, Juge Clinic, Marseille, France;Department of Ophthalmology, Quinze-Vingts National Ophthalmology Hospital, Paris, France;Department of Ophthalmology, Université Paris Cité, Cochin Hospital, APHP, 27 rue du faubourg Saint-Jacques, 75014, Paris, France;stève Consultants, Oullins, France;

关键词: Ophthalmology;    Cataract;    Nd:YAG;    Dataclaims;    Epidemiology;   

DOI  :  10.1186/s12886-023-03134-6

 received in 2023-04-20, accepted in 2023-09-12,  发布年份 2023

来源: Springer

【 摘 要 】

RationaleNd:YAG (neodymium:yttrium-aluminum-garnet) capsulotomy (Nd:YAG-caps) is the gold standard for the treatment of PCO (Posterior Capsule Opacification). There is a lack of real-world data about Nd:YAG-caps use.PurposeThis study’s objectives were to estimate Nd:YAG-caps incidence in France, to describe the patient characteristics, and to analyze the time between surgeries and capsulotomies. Setting: The study was based on data extracted from the EGB database, a 1/97th sample representative of the French population. Design: observational, retrospective, cohort study using national claims data.MethodsFrench adult patients who underwent Nd:YAG-caps between 2014 and 2017 were selected. Main outcomes were the number of patients and procedures performed and the risk factors associated with early Nd:YAG-caps. Results: During the study period, Nd:YAG-caps were performed in 8,425 patients accounting for 10,774 procedures. The extrapolation to the French population led to estimate that 253.103 patients had Nd:YAG-caps, representing 312.103 procedures in 2017. The mean age at Nd:YAG-caps was 75.1 (± 10.2) years. About 36% of patients presented at least one ocular comorbidity. Nd:YAG-caps was performed within 2 years after surgery in 33.0% of patients and within one year in 9.8% of patients. Patients with Nd:YAG-caps within the first year (OR CI95 0.721 [0.673–0.772]) or in the first two years (OR CI95 0.721 [0.673–0.772]) were younger than patients with later Nd:YAG-caps and had a more frequent history of treated ocular diseases (OR 1.516 and 1.178, respectively).ConclusionsThis study brought new real-world and large-scale data regarding Nd:YAG-caps use and gave an updated insight into the patients’ characteristics.

【 授权许可】

CC BY   
© BioMed Central Ltd., part of Springer Nature 2023

【 图 表 】

Fig. 1

Fig. 6